Tianjin No.5 Traditional Chinese Medicine Factory

Tianjin No.5 Traditional Chinese Medicine Factory is a prominent Chinese pharmaceutical manufacturer specializing in the modernization of Traditional Chinese Medicine (TCM). As a core subsidiary of the Tianjin Pharmaceutical Da Ren Tang Group, the company focuses on the research, development, and production of cardiovascular and cerebrovascular treatments. Its flagship product, Nifedipine Sustained-release Tablets (II), is a market leader in China for hypertension management. The facility operates under strict GMP standards and integrates traditional herbal wisdom with modern pharmaceutical delivery technologies, such as sustained-release and targeted formulations. The company plays a vital role in the industrialization of TCM within the Tianjin pharmaceutical cluster.